Category: Pharmaceuticals
-
![Aequus Pharmaceuticals (AQS.V) Sees All, Partners with ReVision Therapeutics to Tackle Stargardt Disease]()
Aequus Pharmaceuticals (AQS.V) Sees All, Partners with ReVision Therapeutics to Tackle Stargardt Disease
I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t enough to satiate my craving for sugar seeing as I would finish the entire thing in just a few days. Eventually, I grew out of my…
-
![Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea]()
Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea
Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene and other cannabinoid distillates into hard-pressed pills that reliably deliver accurately measured dosages with optimal bioavailability. The company’s instant release and extended-release formulations round out a…
-
![BetterLife Pharma (BETR.C) products show promise, but how’s their timing?]()
BetterLife Pharma (BETR.C) products show promise, but how’s their timing?
Drug science is all about timing. You can either take a preexisting molecule, which has benefits for alternative indications rather than what it’s originally on shelves for, and you after proving that it has these benefits during the regulatory dance, you take it to a new market, rebrand it and resell it. Easy. Or you…
-
![Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development]()
Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development
BetterLife is a biotechnology company that develops and commercializes psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. Products Although the table below may seem complex is just a collection of the product names or titles and a description with the type of disease the product…
-
![To Invest or Not: BetterLife Pharma (BETR.C)]()
To Invest or Not: BetterLife Pharma (BETR.C)
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
-
![To Invest or Not: Element Nutritional Sciences (ELMT.C)]()
To Invest or Not: Element Nutritional Sciences (ELMT.C)
In this episode, we take to look at Element Nutritional Sciences (ELMT.C) a nutraceutical company that uses plant-based technology and extensive nutritional research to create health-driven products for customers. We look at the company’s finances, stock price and flagship product Rejuvenate, a proprietary formulation to assist in the rebuilding, restoration, and rejuvenation of natural loss…
-
![First Glance with Jody Vance – Medexus Pharma (MDP.T)]()
First Glance with Jody Vance – Medexus Pharma (MDP.T)
Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other countries to patients in Canada. Listen in! <div algn=”center:><iframe width=”803″ height=”452″ src=”https://www.youtube.com/embed/r4MwrGgePDo” title=”YouTube video player” frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture” allowfullscreen></iframe></div>
-
![Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder]()
Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however, before this turns into a sob story let me assure you that my mom is alive and well after kicking cancer’s ass. My mom was diagnosed…
-
![Medexus (MDP.V) by Mackie Research upgrades their target price by 42%]()
Medexus (MDP.V) by Mackie Research upgrades their target price by 42%
“Medicine is a science of uncertainty and an art of probability.” – William Osler I think it’s appropriate I start the article by saying that I get it, biotech is not an easy industry to understand. The jargon used by those writing about the industry often takes away from the ingenious business models of some…
-
![Bioasis (BTI.V) revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain]()
Bioasis (BTI.V) revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain
Bioasis is a preclinical biopharmaceutical company focused on research and early-stage development of technologies and products for the treatment of patients with the central nervous system, or CNS, diseases, and disorders. In layman’s terms, this is a company that researches and develops products for the diagnosis and treatment of neurological diseases and disorders. The company…
